The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting

Perfusion

Volumn 15, Issue 2, 2000, Pages 143-150

  Bogă, Mehmet ^a   Islamoğlu, Fatih ^a   Badak, Ismail ^a   Çikirikçioğlu, Mustafa ^a   Bakalim, Tamer ^a   Yağdi, Tahir ^a   Büket, Suat ^a   Hamulu, Ahmet ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; HEMOFILTRATION; HUMAN; INFLAMMATION; OXYGENATOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUMP; SYSTEMIC VASCULAR RESISTANCE;

ACUTE-PHASE REACTION; ADULT; AGED; CARDIAC OUTPUT; CORONARY ARTERY BYPASS; FEMALE; HEMATOCRIT; HEMODYNAMIC PROCESSES; HEMOFILTRATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPTERIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULTRAFILTRATION; VASCULAR RESISTANCE;

EID: 1642586756     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910001500209     Document Type: Article

References (24)

1. Cremer J, Martin M, Redl H et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714-20.
2. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
3. Magilligan DJ. Indications of ultrafiltration in the cardiac surgical patient. J Thorac Cardiovasc Surg 1985; 89: 183-89.
4. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56: 1518-22.
5. Wang MJ, Chiu IS, Hsu CM et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg 1996; 61: 651-56.
6. Sander A, Armbruster W, Sander B et al. The influence of continuous hemofiltration on cytokine elimination and the cardiovascular stability in the early phase of sepsis. Contrib Nephrol 1995; 116: 99-103.
7. Grootendorst AF, van Saase JLCM. Blood purification by hemofiltration in septic shock and multiple organ dysfunction syndrome patients. Nephrol Dial Transplant 1996; 11: 312-22.
8. Simon P, Mohl W, Neumann F, Owen A, Punzengruber C, Wolner E. Effects of coronary artery bypass grafting on global and regional myocardial function. J Thorac Cardiovasc Surg 1992; 104: 40-45.
9. Voci P, Bilotta F, Aronson S et al. Echocardiographic analysis of dysfunctional and normal myocardial segments before and immediately after coronary artery bypass graft surgery. Anesth Analg 1992; 75: 213-18.
10. Hennein HA, Ebba H, Rodriguez JL et al. Relationship of the proinflammatory cytokins to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108: 626-35.
11. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia reperfusion. Cardiovasc Res 1996; 32: 743-51.
12. Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion 1991; 6: 41-50.
13. Naik S, Balaji S, Elliott MJ. Modified ultrafiltration improves hemodynamics after cardiopulmonary bypass in children [Abstract]. J Am Coll Cardiol 1992; 19: 37A.
14. Lauer A, Alvis RC, Avram MM. Haemodynamic consequences of continuous arteriovenous haemofiltration in intractable fluid overload. In: La Greca G, Tabris A, Ronco CA eds. Proceedings of the International Symposium on Continuous Arteriovenous Haemofiltration. Milan: Wichtig editore, 1986: 227-31.
15. Coraim FJ, Coraim HP, Ebermann R, Stellwag FM. Acute respiratory failure after cardiac surgery. Clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 1986; 14: 714-18.
16. Walpot B, Geroulanose S, Agloff L, Turina M, Senning A. Reduction of post-bypass hemodilution by hemofiltration. Eur Soc Artif Organs 1979; 6: 315-21.
17. Winton TL, Charette EJP, Salermo TA. The cell-saver during cardiac surgery. Does it save? Ann Thorac Surg 1981; 33: 379-81.
18. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-41.
19. Samsonov M, Fuchs D, Reibnegger G, Belenkov JN, Nassonov EL, Wachter H. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis. Clin Chem 1992; 38: 678-80
20. Millar AB, Armstrong L, Linden JVD et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 56: 1499-502.
21. Fong Y, Moldawer LL, Shires T, Lowry S. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990; 170: 363-78.
22. Wingifield P, Pain RH, Craig S. Tumor necrosis factor is a compact trimer. FEBS Lett 1987; 211: 179-84.
23. Barrera P, Janssen EM, Demacker PN, Wetzels JF, van der Meer JW. Removal of interleukin-1-beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrilonitrile membranes. Lymphokine Cytokine Res 1992; 11: 99-104.
24. Moore RA, Laub GW. Hemofiltration, dialysis, and blood salvage techniques during cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR eds. Cardiopulmonary bypass: principles and practice. Baltimore, MD: Williams & Wilkins, 1994: 93-123.